谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Lurbinectedin As Second- or Third-Line Palliative Therapy in Malignant Pleural Mesothelioma: an International, Multi-Centre, Single-Arm, Phase II Trial (SAKK 17/16).

Y. Metaxas,M. Fruh,E. I. Eboulet,F. Grosso,M. Pless,P. A. Zucali,G. L. Ceresoli,M. Mark,M. Schneider,A. Maconi,M. Perrino, C. Biaggi-Rudolf,P. Froesch,S. Schmid,C. Waibel,C. Appenzeller,D. Rauch,R. von Moos

Annals of oncology（2020）

引用 26|浏览87
暂无评分
关键词
lurbinectedin,mesothelioma,phase II trial
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要